Gilead stock pops 16% after report says coronavirus drug trial shows encouraging early results https://t.co/ftdAXDy4wX 
#markets #globalmarket #stocks #StockMarket #stocktowatch #StockMarketInsights #StockMarketToday #StockMarketNews https://t.co/KvbeJgCvzH